A Humanized and Viable Animal Model for Congenital Adrenal Hyperplasia- CYP21A2 -R484Q Mutant Mouse

• Published in: International journal of molecular sciences 2024-05, Vol.25 (10), p.5062
• Main Authors: Thirumalasetty, Shamini Ramkumar, Schubert, Tina, Naumann, Ronald, Reichardt, Ilka, Rohm, Marie-Luise, Landgraf, Dana, Gembardt, Florian, Peitzsch, Mirko, Hartmann, Michaela F, Sarov, Mihail, Wudy, Stefan A, Reisch, Nicole, Huebner, Angela, Koehler, Katrin
• Format: Article
• Language: English
• Subjects: Ablation; Adrenal Glands - metabolism; Adrenal Glands - pathology; Adrenal Hyperplasia, Congenital - genetics; Adrenal Hyperplasia, Congenital - metabolism; Adrenal Hyperplasia, Congenital - pathology; adrenals; Aldosterone - metabolism; animal models; Animals; CAH; Congenital diseases; Corticosterone - blood; Corticosterone - metabolism; Disease Models, Animal; Enzymes; Female; Females; Genes; Hormones; Humans; Hyperplasia; Male; Males; Mice; Mutation; Ovaries; Progesterone - metabolism; Steroid 21-Hydroxylase - genetics; Steroid 21-Hydroxylase - metabolism
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25105062

Congenital Adrenal Hyperplasia (CAH) is an autosomal recessive disorder impairing cortisol synthesis due to reduced enzymatic activity. This leads to persistent adrenocortical overstimulation and the accumulation of precursors before the blocked enzymatic step. The predominant form of CAH arises from mutations in , causing 21-hydroxylase deficiency (21-OHD). Despite emerging treatment options for CAH, it is not always possible to physiologically replace cortisol levels and counteract hyperandrogenism. Moreover, there is a notable absence of an effective in vivo model for pre-clinical testing. In this work, we developed an animal model for CAH with the clinically relevant point mutation p.R484Q in the previously humanized mouse strain. Mutant mice showed hyperplastic adrenals and exhibited reduced levels of corticosterone and 11-deoxycorticosterone and an increase in progesterone. Female mutants presented with higher aldosterone concentrations, but blood pressure remained similar between wildtype and mutant mice in both sexes. Male mutant mice have normal fertility with a typical testicular appearance, whereas female mutants are infertile, exhibit an abnormal ovarian structure, and remain in a consistent diestrus phase. Conclusively, we show that the animal model has the potential to contribute to testing new treatment options and to prevent comorbidities that result from hormone-related derangements and treatment-related side effects in CAH patients.